InvestorsHub Logo
icon url

BooDog

04/15/15 11:20 AM

#97918 RE: slcimmuno #97915

Excellent post slc. Pleased that we got in the door at ASCO as well.
A lot of good info in your post. As always!!! :-) Thanks for catching the Brilacidin abstracts last night too. I made them a sticky for now till we see the posters come out. Thinking we're hours if not just a few days from getting our full update.
icon url

gostocksgo

04/15/15 11:32 AM

#97921 RE: slcimmuno #97915

Thanks SLC. The ramifications of that Merck/NGM deal (pre-clinical!) are astounding.

FORBES
http://www.forbes.com/sites/greatspeculations/2015/03/03/mercks-partnership-with-ngm-is-a-bold-move/
EXCERPT: Last week Merck signed a deal with NGM Biopharmaceuticals, which we believe is a bold and a long-term move. Under the multi-year agreement, Merck will make a payment of $95 million to NGM to establish a co-development alliance and acquire another 15% equity stake for another $106 million. The company also offered $250 million of additional funding for any new drugs that the biopharma firm develops going forward. The deal gives a lot of flexibility and room for taking risk to NGM. It is a bold move considering there is only one disclosed compound in pre-clinical stage by NGM and it seems that Merck is essentially paying a premium to acquire its team of researchers and scientists.